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CC BY-NC-ND license (http://creativeAbstract Low back pain (LBP) is a major cause of disability and imposes huge economic bur-
dens on human society worldwide. Among many factors responsible for LBP, intervertebral disc
degeneration (IDD) is the most common disorder and is a target for intervention. The etiology
of IDD is complex and its mechanism is still not completely understood. Many factors such as
aging, spine deformities and diseases, spine injuries, and genetic factors are involved in the
pathogenesis of IDD. In this review, we will focus on the recent advances in studies on the most
promising and extensively examined genetic factors associated with IDD in humans. A number
of genetic defects have been correlated with structural and functional changes within the
intervertebral disc (IVD), which may compromise the disc’s mechanical properties and meta-
bolic activities. These genetic and proteomic studies have begun to shed light on the molecular
basis of IDD, suggesting that genetic factors are important contributors to the onset and pro-
gression of IDD. By continuing to improve our understanding of the molecular mechanisms of
IDD, specific early diagnosis and more effective treatments for this disabling disease will be
possible in the future.
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Low back pain (LBP) is a leading cause of disability world-
wide and has tremendous effects on the economy and
quality of life of the patients.1e4 LBP imposes an economic
burden similar to or even greater than that of coronary
heart disease and other major health problems such as
diabetes, Alzheimer’s disease and kidney diseases.5 As the
second most common cause of doctor visits in the USA, LBP
treatment costs $20e100 billion in direct care spending and
contributes $100e200 billion each year in total economic
burden, according to studies about the direct and indirect
costs of LBP published in English from 1997 to 2007.2,6e10
Among many causes of LBP, intervertebral disc degen-
eration (IDD) is the most common diagnosis and target for
intervention. IDD plays a critical role in LBP and correlates
strongly with structural breakdown and dysfunction of the
intervertebral disc (IVD).11,12 The etiology of IDD is complex
and multifactorial, in which aging, certain diseases and
injuries, and genetic factors are involved. Since the
mechanisms of IDD are still not completely understood,
current treatment is largely limited to symptomatic relief
using non-steroidal or steroidal anti-inflammatory medica-
tion and surgical intervention for late-stage IDD with severe
neurological symptoms caused by herniation of IVD.8 A
better understanding of IDD will enable more targeted and
less invasive therapies while keeping people mobile and
functional.3,8 This review article will focus on the recent
advances in understanding the genetic mechanisms of IDD.
The first section is a brief review of the basic structural and
functional characteristics of IVD; the second section sum-
marizes the recent studies on the most promising and
extensively examined genetic factors associated with IDD in
humans.
Structural and functional characteristics of IVD
The IVD is a fibrocartilaginous tissue connecting two adja-
cent vertebral bodies in the spine.13 IVD is an elastic
structure and functions as a weight-bearing cushion which
plays a major role in maintaining flexibility and stability of
the spine.11 The IVD is composed of the external annulus
fibrosus (AF) and the inner gel-like center, the nucleus
pulposus (NP). The central NP consists of a water-based gel-
like avascular substance rich in proteoglycans and a small
amount of collagen type II and elastin fibers; the function of
the elastic NP is to distribute hydraulic pressure in all di-
rections within each disc under compressive loads.7,11 The
outer region AF encloses the NP with a type I collagen-
based concentric lamellar structure.8,11 Within each
lamella, the collagen fibers are aligned approximately 30
with respect to the transverse plane of the vertebral end-
plates (EP). There are two thin EPs, which extend superi-
orly and inferiorly over the inner AF and NP and supply
nutrients to discs by diffusion. The EPs consist of osseous
and hyaline-cartilaginous layers and connect the interver-
tebral disc to the vertebral bodies. Only NP and the inner
AF are covered by the cartilaginous endplates. The collagen
fibers of the outer AF anchor directly into the bone of the
apophyseal ring. There is no distinct border between the NP
and the inner AF.11There are different cell types located in various regions of
the IVD. The cartilaginous EPs contain rounded chon-
drocytes, similar to the hyaline cartilage in other locations.
The cells in the outer AF are elongated and fibroblast-like,
whereas in the most inner zone of AF and the NP, the cells
become more spheroidal and chondrocyte-like. The NP
contains a relatively small number of fibroblasts and more
numerous chondrocyte-like cells (Fig. 1A). The cell types of
cartilaginous EP and AF remain relatively constant
throughout their life. However, the NP goes through sub-
stantial cell type changes early in life.7,14 Cells in NP at birth
are largely of notochordal origin, but in most humans, the
number of notochordal cells decreases rapidly after birth
and eventually becomes undetectable at about 4e10 years
of age.15 At the same time, the NP is gradually populated
with chondrocyte-like cells, probably originating and
migrating from the cartilaginous EPs and the inner AF.7
Although the detailed mechanism of this cell type transi-
tion is still unknown, it has been assumed that Fas, amember
of the tumor necrosis factor receptor family, plays a role in
this process. Apoptosis induced by an autocrine or paracrine
Fas-mediated counterattack may be important in this tran-
sition.14,16 Human notochordal cells gradually disappear
with aging, which correlates with disc degeneration. These
observations suggest that the notochordal cell population
may be involved in maintenance and regeneration of IVD.17
However, the transplantation of notochordal cells into IVD
to reverse degeneration is not feasible clinically, because it
relies on the removal of notochordal cells at an early age.
The use of soluble factors produced by notochordal cells may
be more practical than cell transplantation.3,8,14
The extracellular matrix (ECM) composition is very
important for IVD structure and function because changes
in ECM can eventually contribute to IDD.3 Type I and II
collagens are the main components of IVD. Peripheral AF
ECM contains mostly type I collagen with relatively low
proteoglycan and water content. ECM of the inner AF be-
comes higher in type II collagen and proteoglycans. In
general, collagens account for approximately 60% of the AF
dry weight whereas proteoglycans account for approxi-
mately 25%. Other collagen types, such as type XI and type
IX collagens, which play a role in assembly of type II
collagen fibers and formation of crosslinks between the
adjacent collagen fibrils, comprise a small portion of ECM.
In comparison with the AF, the ECM in NP contains more
type II collagen and proteoglycans, the function of which is
to maintain water content and to withstand conductive
pressure. Aggrecan, the most common proteoglycan, con-
stitutes up to 50% of NP dry weight and is responsible for
osmotic properties and helps maintain disc height and
ability to withstand compression.3,9
During the course of growth and skeletal maturation,
under the influence of both intrinsic and extrinsic factors,
the boundary between NP and AF becomes less obvious.
The nucleus generally becomes more fibrotic and less gel-
like, while the annular lamellae become irregular with
disorganized collagen and elastin networks. During the
progression of IDD, cleft formation with fissuring is usually
seen within the disc, especially in the nucleus. Degenera-
tion of the AF allows the NP to push out towards the outer
AF causing disc bulge (Fig. 1B). Complete rupture of the AF
allows the NP to protrude beyond the boundary of the disc
Figure 1 (A) Left panel: An illustration shows a cut out portion of a normal disc. Note the relationships between nucleus pul-
posus, annulus fibrosus, and vertebral endplate. Right panel: An enlargement of NP part of the disc. The NP contains collagen fibers
and elastin fibers, both of which are embedded in highly hydrated aggrecan-containing gel. The NP also contains numerous
chondrocyte-like cells with dark round nuclei as well as a relatively small number of fibroblasts with elongated nuclei. The
chondrocyte-like cells usually exhibit close spatial groupings and are arranged either in rows among the collagen fibers or in
isogenous group. (B) Illustrations showing normal and degenerated intervertebral disc (IVD). The central nucleus pulposus is
enclosed by outer annulus fibrosus. When degeneration occurs, the nucleus pulposus becomes more fibrotic and less gel-like, while
the annulus fibrosus becomes irregular and disorganized. Cleft formation can be observed, especially in the nucleus pulposus
(arrow head), which can even be pushed out beyond the boundary of the disc due to deterioration of the annulus fibrosus (arrow).
180 Y. Feng et al.(herniation of IVD/NP) and pressure on the spinal cord and/
or nerve root depending on the location of disc herniation.
In addition, nerve and blood vessel formation, cell prolif-
eration and cell death can also be found in and around the
degenerated IVD.6Genetic factors involved IDD
Current therapeutic strategies to alleviate low back pain
resulting from IDD generally lie in conservative treatments,
which include physiotherapy and anti-inflammatory medi-
cation. Although these conservative strategies are often
effective to relieve symptoms, actual causes of the degen-
eration are not addressed. To enable more targeted and less
invasive therapies, it is imperative to have a more thorough
understanding about the etiology and pathogenetic mecha-
nisms of IDD. Though huge efforts have been put into IDD
research and substantial progress has been made, the real
cause of IDD is still largely unclear. It is believed that IDD and
associated degenerative entities such as disc herniation are
attributed to many different factors, both biological andenvironmental. Certain factors, such as aging, injury and
spinal deformity, have been proposed and investigated, and
their contributions to IDD are acknowledged.6,18,19
New genetic and proteomic tools have begun to promote
our understanding of themolecular basis of diseases. Insights
gained from several studies suggest that genetic factors are
critical contributors to the onset and progression of
IDD.9,13,20e22 However, it is still unknown whether a specific
gene effect of relatively largemagnitudeexists or the genetic
contribution is due to the sum of small effects ofmany genes.
Identification of specific genetic influences on the develop-
ment of IDD will provide us key insights into the molecular
mechanism of the disease. This review is not intended to
cover all of the genes involved in IDD; rather, wewill discuss a
few most promising and extensively studied gene loci closely
associated with the pathogenesis of IDD in humans.Collagen I
Collagen I (Type I collagen) is an important protein in the
skin, ligament, and bone. It is a heterotrimeric protein
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differs.13,23,24 The genes encoding collagen I, COL1A1 and
COL1A2 are present in both NP and AF. Although the
mechanism by which genetic alterations of collagen I in-
fluence the development of IDD is not fully understood,
polymorphisms of COL1A1 gene have been reported to in-
crease the risk of IDD in different population studies. In a
Dutch population (65- to 85-year-old) with TT genotype of
collagen type I aI (COL1A1) Sp1 polymorphism, their risk of
disc degeneration was found to be higher than people with
GG and GT genotypes,23 suggesting (COL1A1) Sp1 poly-
morphism may be a genetic risk factor related to IDD in
older people. In another study carried out in Greek military
recruits, some young soldiers were diagnosed with early
lumbar disc degeneration at the time of their presentation
to a military training site. Genetic analyses indicated that
33.3% people in this population with lumbar disc disease
had TT genotype polymorphism of COL1A1 Sp1 binding site;
in contrast, no healthy people in the control group had the
TT genotype.24 In a more recent Twin Spine Study from the
population-based Finnish Twin Cohort, a specific IVD
phenotype (disc signal intensity on magnetic resonance
imaging) was strongly associated with allelic variants of
COL1A1 gene (rs2075555; P Z 0.005).25e27 These findings
strongly suggest that COL1A1 is a candidate gene associated
with the pathogenesis of disc degeneration.26Collagen IX
Collagen IX is a heterotrimeric protein consisting of 3
genetically distinct chains, a1, a2 and a3, encoded by the
COL9A1, COL9A2, and COL9A3 genes, respectively.13 Both
AF and NP contain small amounts of collagen IX, which is
thought to serve as a bridge between collagens and non-
collagenous proteins in tissues. Mutations in COL9 genes
are known to affect disc degeneration in both mice and
humans. Transgenic mice with an overexpression of mutant
Col9a1 and mice with an inactivated Col9a1 were found to
have accelerated disk degeneration and more herniation
than the age-matched control group.28,29 The COL9A2 gene,
which codes for the a2 chain of collagen IX, was screened
for sequence variations in individuals with IDD in a Finnish
population. Trp2, a rare COL9A2 allele that replaces the
wild-type arginine with tryptophan, was found in 6 of 157
patients, but absent in 174 controls.30 Coinheritance of the
Trp2 allele and the phenotype was studied in the families of
four original patients. All members who had inherited the
allele in those families developed intervertebral disc dis-
ease. A large cohort study of 804 Chinese individuals
confirmed the above finding. The Trp2 allele was related to
a 4-fold increase of annular tears in patients aged from 30
to 39 years, a 2.4-fold increase in disc degeneration defined
by magnetic resonance imaging (MRI), and disc herniation in
patients aged between 40 and 49. It has been found that
one-fifth of Chinese population bear the Trp2 allele.31
However, the Trp2 association was not replicated in a
German study of 250 patients.32
In relation to the tryptophan allele Trp3 of COL9A3 gene,
a 3-fold risk of IDD with the allele was shown in Finnish
studies. The Trp3 allele was found in 24% of patients and 9%
of controls in one study30 and 12.3% of 171 patientscompared with 4.7% of 186 controls in another study
(P Z 0.000013).33 Solovieva et al. confirmed Trp2 associa-
tion with disc degeneration and also noted a geneegene
interaction with an IL-1b polymorphism (rs1143634).34
Those with the Trp3 allele without the IL-1b poly-
morphism had an increased risk of signal intensity changes,
but there was no effect on the IL-1b polymorphism. This
significant change suggests that Trp3 is modified by an
additional and seemingly irrelevant polymorphism or that
the IL-1b polymorphism is a negative confounder with an
unknown single complementary third factor.34 In contrast,
similar association was not found in Greek pa-
tients.25,26,33,35 Therefore, further research with distinctive
environmental, ethnic, and age factors is needed to
establish a realistic association between the Trp alleles in
COL9A2 and COL9A3 and disc degeneration.
Collagen XI
Type XI collagen is a cartilage-specific ECM protein impor-
tant for cartilage-collagen fibril formation and for ECM or-
ganization. It consists of 3 a chains, which are encoded by
COL11A1, COL11A2, and COL11A3 genes. The 3 chains fold
into triple-helical heterotrimers to form procollagen, which
is secreted into the ECM, where it participates in fibril
formation with other specific collagens and regulates the
diameter of cartilage collagen fibrils. Because of the
interaction with collagen type II and IX in IVD, collagen XI
and its encoding genes have been targeted as possible
contributors to disc diseases. A strong association between
the single-nucleotide polymorphism (SNP) in COL11A1 gene
and lumbar disc herniation in Japanese patients with lum-
bar disease has been identified.36 Furthermore, the same
study also found that Col11A1 mRNA was substantially
expressed in healthy IVD, whereas its expression in patients
with lumbar disc herniation was decreased along with the
increase of degeneration severity. This finding suggests that
the susceptibility of SNP produces unstable Col11A1 tran-
scripts. Solovieva et al. found that a sequence variation in
Intron 9 of Col11A2 was associated with an increased risk of
disc bulges compared with those people without this poly-
morphism.34 Another large study conducted in 588 Finnish
men found that two Col11A1 and three Col11A2 poly-
morphisms were associated with MRI-defined disc bulges
and signal intensity. These polymorphisms may play a role
in producing unstable transcripts of the disease-associated
allele. Instability of gene transcription would cause
decreased functional collagen and subsequent disc
degeneration.27
Aggrecan
Aggrecan is a proteoglycan that interacts with hyaluronan
to form large aggregates, which are responsible for the
ability of the tissues to resist compressive loads.37 This
function is related to the structure of aggrecan, specifically
to the large number of chondroitin sulfate chains present
on its core protein. The chondroitin sulfate chains are
located in two adjacent regions of the aggrecan core pro-
tein, termed the CS1 and CS2 domains. The human aggre-
can gene (ACAN ) possesses variable numbers of tandem
182 Y. Feng et al.repeat polymorphisms in the part of exon 12 encoding the
CS1 domain. Alleles have been identified with CS1 repeat
numbers ranging from 13 to 33, with 26, 27, or 28 repeats
being the most common. This can result in variation in the
degree of chondroitin sulfate substitution of aggrecan in
different individuals and raise the possibility that the
functional properties of aggrecan may vary between in-
dividuals. Those people with an inferior aggrecan structure
may be more vulnerable to IDD and cartilage degenera-
tion.38 Research from Kawaguchi et al. indicated that sub-
jects with shorter variable numbers of tandem repeat
length of the ACAN gene are at risk of developing multilevel
disc degeneration at an early age.39 However, no correla-
tion between ACAN CS1 polymorphism and IDD in 44 pa-
tients was established in research from Roughly et al.40
Therefore, current data are not sufficient to establish a
strong association between the ACAN gene polymorphisms
and IDD.Interleukin-1 (IL-1)
IL-1 is a cytokine produced in response to inflammation,
injury, or antigenic challenge.13,41e43 There are 3 members
in IL-1 gene family: IL-1a, IL-1b, and IL-1 receptor antag-
onist (IL-1RN ). The first 2 are strong inducers of inflam-
mation, whereas IL-1RN is a suppressor of IL-1 because it
competitively inhibits the binding of IL-1 to its receptors.
Excessive and/or dysregulated activity of IL-1 is related to
tissue destruction. Therefore, its synthesis, secretion, and
biological activity are strongly associated with inflamma-
tory disorders. When compared with normal IVDs, degen-
erated discs spontaneously produce increased amounts of
IL-1 cytokines, with an increase in IL-1a and IL-1b,
without an increase in IL-1RN. Furthermore, IL-1b has the
tendency to upregulate itself, whereas IL-1a downregulates
IL-1RN, further increasing the cytokine expression within
the IVD.25,26
IL-1 increases gene expression of MMP-3, MMP-9, and
MMP-13, which are ECM degrading enzymes.44 At the same
time, IL-1 decreases the expression of normal ECM mole-
cule genes.45 Cells derived from degenerative discs showed
upregulated expression of an aggrecanase ADAMTS-4 in the
presence of IL-1.25,45 In a study involving 133 Finnish men,
evidence has shown the effect of the IL-1 gene poly-
morphism locus on the risk of lumbar disc degeneration.46 A
more than 3-fold increase in the risk of disc degeneration
was observed in people with 2 IL-1a T889 alleles, compared
to people without them. Additionally, a 2-fold increased
risk for disc bulges was found in people carrying IL-1a C889-
T or IL-1b C3954-T alleles. In another study by Karppinen
et al., a 2.5-fold increased risk of endplate “Modic
changes” was found in carriers of allele IL-1a C889-T.47
Modic changes are vertebral endplate and adjacent bone
marrow changes visible in MRI, which are classified into 3
types: Type I shows a low signal intensity (SI) in T1-
weighted images (T1WI) and a high SI in T2-weighted im-
ages (T2WI), indicating an ongoing active inflammatory
degenerative process. Type II shows a high SI both in T1WI
and in T2WI, reflecting fatty degeneration of the bone
marrow. Type III shows a low SI both in T1WI and in T2WI,
demonstrating a late regenerative process.47Interleukin-6 (IL-6)
Proinflammatory cytokine IL-6 has been correlated with the
presence of either lower back pain or sciatica.41 A Finnish
study showed that the risk allele (A allele) in an IL-6 SNP in
Exon 5 (rs13006435) was strongly associated with IDD pa-
tients, compared with the controls.48 In another study
analyzing the other three SNPs of IL-6 (rs1800797,
rs1800796, rs1800795), the GCG haplotype was found to be
associated with early development of disc degeneration in
Danish girls, but not in boys. However, the difference be-
tween genders may result from the relatively small sample
size.49 IDD and associated sciatica is characterized by tissue
destruction, inflammation and pain, all of which correspond
the functions of IL-6.
Matrix metalloproteinase-3 (MMP-3)
One of the important pathological processes in IDD is the
degradation of the disc matrix by enzymes such as matrix
metalloproteinases (MMPs).50 MMP-3 is a potent
proteoglycan-degrading enzyme that plays important role
in IDD. Local conditions, such as mechanical loading and
inflammation, may induce MMP-3 expression.38 Takahashi
et al. reported that MMP-3 gene polymorphism (5A/6A) was
linked to IDD in an elderly Japanese population (age 64 to
94). Compared with the 6A6A genotype, a significantly
larger number of degenerative IVDs was observed in people
with 5A5A and 5A6A genotypes.51 The association between
MMP-3 and IDD was replicated in another study of 720 En-
glish women.52 In contrast, no association between IDD and
MMP-3 was found in the study by Noponen-Hietala et al. of
29 Finnish probands with degenerative spinal stenosis
(evaluated by MRI).25,26,53 Therefore, more studies are
required to confirm the association between MMP-3 poly-
morphism and IDD.
Vitamin D receptor (VDR)
VDR mediates the function of Vitamin D and plays a role in
normal bone mineralization and remodeling. Its association
with degenerative disc disease has been validated in large
populations of different ethnic backgrounds, including
Chinese, Japanese, Finnish and English. VDR gene poly-
morphisms are believed to contribute to specific disorders,
such as osteoporosis, osteoarthritis, and degenerative disc
disease.13,38 The relationship between two VDR poly-
morphisms (TaqI and FokI) and disc degeneration has been
studied extensively. The first polymorphism, TaqI is located
in a noncoding region of Exon 9.54 The Tt and the tt geno-
types of Taq I polymorphism of VDR gene have been related
to disc degeneration. Videman et al. showed that quanti-
tatively assessed signal intensities using MRI in thoracic and
lumbar discs in men with Taq I tt and Tt genotype were
worse by 12.9% and 4.5%, respectively, than men with the
TT genotype.55 Comparable findings can be seen in research
of Kawaguchi et al. who reported that Tt allele of the VDR
gene was found more frequently in Japanese patients with
multilevel and more severe disc degeneration than in pa-
tients with the TT allele.56 In a study of 804 Chinese pa-
tients, it was found that individuals with at least 1 t allele
Table 1 Additional genetic factors that may be involved in the pathogenesis of IDD.
Gene name References Population Comments
MMP-2 Dong et al., 200760 162 young Chinese
individuals (25.4  3.5
years of age)
3-fold higher risk for lumbar disc disease in individuals with the
MMP-2-1306CC genotype compared with individuals with at
least 1 variant T allele
MMP-9 Sun et al., 200961 408 individuals with IDD
from north China
A 2-fold increased risk of IDD found in individuals with CT/TT
genotype compared with individuals with CC genotype
IGF-1R Urano et al., 200859 434 postmenopausal
Japanese women
The G allele (GG and GC) of the IGF-1R gene was
overrepresented in the population showing more severe disc
space narrowing on radiographs
CILP Seki et al., 200562 467 Japanese men
and women
CILP plays a role in lumbar disc degeneration by regulating
TGF-beta signaling pathway
TIMP1
COX2
THSD2
Valdes et al., 200552 700 English women Polymorphisms of TIMP1, COX2 and THSD2 were associated
with progression of IDD
Figure 2 Intervertebral disc degeneration can be attributed
to many different factors, including genetic factors as well as
aging, injury, spine deformity (e.g. scoliosis and kyphosis).
These biological and environmental factors may lead to the
spine being susceptible to stress and abnormal gene expres-
sion. As a result, increased catabolic activity and decreased
anabolic activity may occur in the intervertebral disc, leading
to intervertebral disc degeneration.
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degenerative disc disease when compared to individuals
with the T allele.25,54 The second polymorphism, FokI, is
located in Exon 2 and appears at the first of the two po-
tential translation initiation sites of VDR cDNA.57 Individuals
with the ff and Ff genotypes had mean signal intensities
that were 9.3% and 4.3% lower, respectively, than those
with FF genotypes. The summary scores of qualitatively
assessed signal intensity, bulging, and disc height were 4.0%
and 6.9% worse in individuals with Ff and ff genotypes,
compared to those with the FF genotype.58
It is not clear how the genetic variants of the VDR gene
affect IDD. It was speculated that this polymorphism might
alter the structural characteristics of the matrix in IVD. In
addition, it is possible that VDR gene polymorphism only
functions as a marker for other genes, rather than being
directly involved in the pathogenesis of IDD. The type II
collagen gene (COL2A1) and insulin-like growth factor (IGF )
type-1 gene are located close to VDR gene on chromosome
12. The physical distance between VDR gene and COL2A1
gene is less than 740 kb. IGF is expressed in intervertebral
disc tissue, and IGF-1 stimulates proteoglycan synthesis in
cells of the NP.26 Further study of the linkage of the VDR
gene and its nearby genes might help the evaluation of the
genetic background of IDD.
Other genes
Several other genes, such as IGF-1R,59 MMP-2,60 MMP-9,61
CILP,62 TIMP1, COX2 and THSD252 that may also be
involved in spine degeneration are listed in Table 1.
Conclusions and future directions
Investigations on the origin of IDD have evolved from the
classic aging and wear-and-tear theory to a sophisticated
multiple-causative disease involving molecular and genetic
changes. A number of genetic defects have been correlated
with IDD in both animals and humans. Genetic factors with
or without the presence of other risk factors (e.g. aging,
spine injury, spine deformity) may cause IDD through both
mechanical and biological mechanisms. For example,genetic defects may result in structural and functional
changes of specific collagens within the IVD, which
compromise the disc’s mechanical properties and thus its
susceptibility to external stress. Abnormal mechanical
properties of the disc tissue may further deteriorate the
metabolic changes, such as decreased synthesis (anabolic
184 Y. Feng et al.activity) and increased breakdown (catabolic activity) of
the ECM structural proteins, leading to higher incidence of
IDD in certain populations relative to others.63 (Fig. 2).
Recent heredity and linkage studies have certainly
improved our understanding of the etiology of IDD; how-
ever, the magnitude and mechanism of influence of the
genetic factors on the development of IDD are still not fully
understood. Some of the genetic studies were based on
small cohort sizes, which may lead to false positive and
false negative errors. Future genetic studies should
combine patient resources and proceed with more focused,
directed analyses of susceptibility loci in large patient co-
horts. In addition, it would be important to explore genetic
defects in more upstream regulators of specific genes
associated with IDD. For example, transcription factors
SOX9 and NFAT1 regulate the expression of multiple
anabolic and catabolic genes and mediate the matrix pro-
duction in articular cartilage64,65; it would be valuable to
further investigate whether genetic alterations in these
upstream regulators exist and are involved in the devel-
opment of IDD. With the advances in imaging technology
and molecular and cellular biology including genetic
studies, specific early diagnoses and more targeted treat-
ments for this costly and disabling disease will become
possible in the future.
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